Cyclin D1 expression and cell cycle response in DNA mismatch repair-deficient cells upon methylation and UV-C damage

被引:14
作者
Lützen, A [1 ]
Bisgaard, HC [1 ]
Rasmussen, LJ [1 ]
机构
[1] Roskilde Univ Ctr, Dept Chem & Life Sci, DK-4000 Roskilde, Denmark
关键词
mismatch repair; cancer; HNPCC; cyclin D1; apoptosis;
D O I
10.1016/j.yexcr.2003.08.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have evaluated cell survival, apoptosis, and cell cycle responses in a panel of DNA mismatch repair (MMR)-deficient colon and prostate cancer cell lines after alkylation and UV-C damage. We show that although these MMR-deficient cells tolerate alkylation damage, they are as sensitive to UV-C-induced damage as are the MMR-proficient cells. MMR-proficient cells arrest in the S-G2 phase of the cell cycle and initiate apoptosis following alkylation damage, whereas MMR-deficient cells continue proliferation. However, two prostate cancer cell lines that are MMR-deficient surprisingly arrest transiently in S-G2 after alkylation damage. Progression through G1 phase initially depends on the expression of one or more of the D-type cyclins (D1, D2, and/or 133). Analysis of cyclin D1 expression shows an initial MMR-independent decrease in the protein level after alkylation as well as UV-C damage. At later time points, however, only DNA damage-arrested cells showed decreased cyclin D1 levels irrespective of NMR status, indicating that reduced cyclin D1 could be a result of a smaller fraction of cells being in G1 phase rather than a result of an intact MMR system. Finally, we show that cyclin D1 is degraded by the proteasome in response to alkylation damage. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 35 条
[1]   Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage [J].
Agami, R ;
Bernards, R .
CELL, 2000, 102 (01) :55-66
[2]  
Bala S, 2001, CANCER RES, V61, P6042
[3]  
Berardini M, 2000, J BIOL CHEM, V275, P27851
[4]  
BETTICHER DC, 1995, ONCOGENE, V11, P1005
[5]   Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine [J].
Carethers, JM ;
Hawn, MT ;
Chauhan, DP ;
Luce, MC ;
Marra, G ;
Koi, M ;
Boland, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :199-206
[6]  
Chen B, 1999, WORLD J GASTROENTERO, V5, P18
[7]   Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes [J].
Clark, AB ;
Valle, F ;
Drotschmann, K ;
Gary, RK ;
Kunkel, TA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36498-36501
[8]   Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway [J].
Diehl, JA ;
Zindy, F ;
Sherr, CJ .
GENES & DEVELOPMENT, 1997, 11 (08) :957-972
[9]   Glycogen synthase kinase 3β regulates cyclin D1 proteolysis and subcellular localization [J].
Diehl, JA ;
Cheng, MG ;
Roussel, MF ;
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (22) :3499-3511
[10]   Human MutS alpha recognizes damaged DNA base pairs containing O-6-methylguanine, O-4-methylthymine, or the cisplatin-d(GpG) adduct [J].
Duckett, DR ;
Drummond, JT ;
Murchie, AIH ;
Reardon, JT ;
Sancar, A ;
Lilley, DM ;
Modrich, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6443-6447